Profile data is unavailable for this security.
About the company
Jiangsu Cowin Biotech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of molecular detection products. The Company is also in the business of molecular testing services. Molecular detection products include molecular detection raw materials enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The Company's products are exported to the United States, Peru, Germany and other countries and regions.
- Revenue in CNY (TTM)118.17m
- Net income in CNY-144.51m
- Incorporated2010
- Employees657.00
- LocationJiangsu Cowin Biotech Co LtdNo. 18 Zelan RoadMedical High tech ZoneTAIZHOU 225311ChinaCHN
- Phone+86 52 386200880
- Fax+86 52 386200880
- Websitehttps://www.cwbio.com/
More ▼
Mergers & acquisitions
| Acquired company | 688426:SHH since announced | Transaction value |
|---|---|---|
| Shanghai Haoweitai Bio-Technology Co Ltd | -14.96% | 1.79m |
Data delayed at least 15 minutes, as of Nov 15 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allgens Medical Technology Co Ltd | 191.19m | 5.11m | 2.39bn | 202.00 | 505.17 | 1.68 | -- | 12.48 | 0.0348 | 0.0348 | 1.45 | 10.49 | 0.1251 | 1.32 | 2.81 | 946,490.30 | 0.0232 | 7.62 | 0.0241 | 8.30 | 73.87 | 83.60 | 0.1855 | 39.05 | 24.27 | -- | 0.0333 | 5.25 | -7.68 | 12.86 | -43.04 | 10.46 | -26.12 | -- |
| Jiangsu Cowin Biotech Co Ltd | 118.17m | -144.51m | 2.59bn | 657.00 | -- | 1.69 | -- | 21.93 | -1.30 | -1.30 | 1.06 | 13.63 | 0.0667 | 1.32 | 1.43 | 179,863.40 | -8.45 | -- | -8.93 | -- | 53.54 | -- | -126.60 | -- | 13.60 | -- | 0.0214 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
| Nanjing Medlander Medical Tech Co Ltd | 380.95m | 101.15m | 2.60bn | 481.00 | 25.35 | 1.98 | -- | 6.81 | 1.02 | 1.02 | 3.86 | 13.10 | 0.2527 | 1.98 | 21.47 | 791,989.40 | 7.06 | -- | 7.76 | -- | 71.46 | -- | 27.94 | -- | 7.57 | -- | 0.0115 | -- | -9.57 | -- | -26.19 | -- | -- | -- |
| Beijing Hotgen Biotech Co Ltd | 520.50m | -67.64m | 2.80bn | 1.04k | -- | 0.8585 | -- | 5.38 | -0.7349 | -0.7349 | 5.74 | 35.25 | 0.1484 | 2.20 | 5.85 | 502,410.60 | -2.13 | 29.65 | -2.22 | 34.70 | 46.98 | 56.08 | -14.33 | 32.26 | 8.95 | -- | 0.0026 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
| Chemclin Diagnostics Co Ltd | 443.86m | 139.29m | 2.93bn | 731.00 | 21.00 | 2.09 | -- | 6.60 | 0.3476 | 0.3476 | 1.11 | 3.49 | 0.2491 | 1.00 | 16.34 | 607,195.30 | 7.82 | 11.01 | 8.73 | 12.32 | 74.89 | 74.19 | 31.38 | 31.07 | 5.16 | -- | 0.1515 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 422.21m | 112.74m | 2.96bn | 700.00 | 26.16 | 1.84 | -- | 7.01 | 1.18 | 1.18 | 4.42 | 16.83 | 0.2401 | 3.12 | 12.37 | 603,153.40 | 6.41 | 10.27 | 6.92 | 11.43 | 70.21 | 73.26 | 26.70 | 33.99 | 8.31 | -- | 0.0003 | 47.57 | 43.72 | 17.34 | 45.22 | 16.55 | 26.69 | -- |
| Beijing Succeeder Technology Inc | 297.74m | 112.75m | 3.03bn | 296.00 | 26.95 | 1.85 | -- | 10.18 | 1.06 | 1.06 | 2.80 | 15.41 | 0.1766 | 2.51 | 8.66 | 1,005,870.00 | 6.69 | 7.77 | 7.02 | 8.25 | 60.39 | 61.03 | 37.85 | 38.34 | 14.78 | -- | 0.00004 | 22.22 | 20.40 | 6.60 | 12.29 | 15.57 | 99.03 | -- |
| Cowealth Medical China Co Ltd | 970.41m | 29.67m | 3.04bn | 240.00 | 102.39 | 2.60 | -- | 3.13 | 0.0745 | 0.0745 | 2.44 | 2.93 | 0.6435 | 3.90 | 1.25 | 4,043,355.00 | 2.01 | 5.80 | 2.59 | 8.09 | 19.62 | 20.74 | 3.13 | 6.14 | 3.65 | -- | 0.0829 | 23.89 | -14.62 | 3.85 | -42.96 | -6.75 | 32.85 | -- |
Data as of Nov 15 2024. Currency figures normalised to Jiangsu Cowin Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
41.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 4.68m | 18.31% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 2.32m | 9.06% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 1.50m | 5.88% |
| SWS MU Fund Management Co., Ltd.as of 30 Jun 2024 | 1.24m | 4.87% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 383.92k | 1.50% |
| Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2024 | 194.35k | 0.76% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 172.17k | 0.67% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024 | 89.37k | 0.35% |
| China International Capital Corp. HK Asset Management Ltd.as of 30 Jun 2024 | 82.19k | 0.32% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 54.50k | 0.21% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
